The Investigation of the Cox-2 Selective Inhibitor Parecoxib Effects in Spinal Cord Injury in Rat

REFERENCES

• Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol. 2008;209:378–388. doi:10.1016/j.expneurol.2007.06.009. PMID: 17662717.
   PubMed Web of Science ®Google Scholar
• Bao F, Chen Y, Dekaban GA, Weaver LC. An anti-CD11d integrin antibody reduces cyclooxygenase-2 expression and protein and DNA oxidation after spinal cord injury in rats. J Neurochem. 2004;90:1194–1204.doi:10.1111/j.1471-4159.2004.02580.x. PMID: 15312174.
   PubMed Web of Science ®Google Scholar
• Hoffmann C. COX-2 in brain and spinal cord implications for therapeutic use. Curr Med Chem. 2000;7:1113–1120. doi:10.2174/0929867003374282. PMID: 11032961.
   PubMed Web of Science ®Google Scholar
• Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem. 1996;271:33157–33360. doi:10.1074/jbc.271.52.33157. PMID: 8969167.
   PubMed Web of Science ®Google Scholar
• Vanegas H, Schaible HG. Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord. Prog Neurobiol. 2001;64:327–363. doi:10.1016/S0301-0082(00)00063-0. PMID: 11275357.
   PubMed Web of Science ®Google Scholar
• Adachi K, Yimin Y, Satake K, et al. Localization of cyclooxygenase-2 induced following traumatic spinal cord injury. Neurosci Res. 2005;51:73–80.doi:10.1016/j.neures.2004.10.007. PMID: 15596243.
   PubMed Web of Science ®Google Scholar
• Resnick DK, Nguyen P, Cechvala CF. Selective cyclooxygenase 2 inhibition lowers spinal cord prostaglandin concentrations after injury. Spine J. 2001;1:437–441. doi:10.1016/S1529-9430(01)00117-6. PMID: 14588302.
   PubMedGoogle Scholar
• Bayly CI, Black WC, Léger S, Ouimet N, Ouellet M, Percival MD. Structure-based design of COX-2 selectivity into flurbiprofen. Bioorg Med Chem Lett. 1999;9:307–312. doi:10.1016/S0960-894X(98)00717-3. PMID: 10091674.
   PubMed Web of Science ®Google Scholar
• Dannhardt G, Laufer S. Structural approaches to explain the selectivity of COX-2 inhibitors: is there a common pharmacophore? Curr Med Chem. 2000;7:1101–1112. doi:10.2174/0929867003374237. PMID: 11032960.
   PubMed Web of Science ®Google Scholar
• Marnett LJ. Recent developments in cyclooxygenase inhibition. Prostaglandins Other Lipid Mediat. 2002;68–69:153–164. doi:10.1016/S0090-6980(02)00027-8. PMID: 12432915.
   PubMed Web of Science ®Google Scholar
• Rivlin AS, Tator CH. Effect of duration of acute spinal cord compression in a new acute cord injury model in the rat. Surg Neurol. 1978;10:38–43. PMID: 684604.
   PubMedGoogle Scholar
• Bakar B, Köse EA, Kupana Ayva S, Sarkarati B, Kasımcan MO, Kılınç K. Effects of low-dose methotrexate in spinal cord injury in rats. Ulus Travma Acil Cerrahi Derg. 2013;19:285–293. doi:10.5505/tjtes.2013.65475. PMID:23884668.
   PubMed Web of Science ®Google Scholar
• Black P, Markowitz RS, Cooper V, et al. Models of spinal cord injury: part 1. Static load technique. Neurosurgery. 1986;19:752–762.
   PubMed Web of Science ®Google Scholar
• Dincel GC, Atmaca HT. Nitric oxide production increases during Toxoplasma gondii encephalitis in mice. Exp Parasitol. 2015;156:104–112. doi:10.1016/j.exppara.2015.06.009. PMID: 26115941.
   PubMed Web of Science ®Google Scholar
• Armstrong D, al-Awadi F. Lipid peroxidation and retinopathy in streptozotocin-induced diabetes. Free Radic Biol Med. 1991;11:433–436. doi:10.1016/0891-5849(91)90161-U. PMID: 1797628.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275.
   PubMed Web of Science ®Google Scholar
• Bracken MB, Shepard MJ, Holford TR, et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third national acute spinal cord injury randomized controlled trial. national acute spinal cord injury study. JAMA. 1997;277:1597–1604. doi:10.1001/jama.1997.03540440031029. PMID: 9168289.
   PubMed Web of Science ®Google Scholar
• Eck JC, Nachtigall D, Humphreys SC, Hodges SD. Questionnaire survey of spine surgeons on the use of methylprednisolone for acute spinal cord injury. Spine (Phila Pa 1976). 2006;31:E250–E253.doi:10.1097/01.brs.0000214886.21265.8c. PMID: 16641765.
   PubMed Web of Science ®Google Scholar
• Gerndt SJ, Rodriguez JL, Pawlik JW, et al. Consequences of high-dose steroid therapy for acute spinal cord injury. J Trauma. 1997;42:279–284. doi:10.1097/00005373-199702000-00017. PMID: 9042882.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Tamaki T, Kawakami M, Yoshida M, Ando M, Yamada H. Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury. Spine (Phila Pa 1976). 2001;26:426–30. doi:10.1097/00007632-200102150-00020. PMID: 11224891.
   PubMed Web of Science ®Google Scholar
• Poynton AR, O'Farrell DA, Shannon F, Murray P, McManus F, Walsh MG. An evaluation of the factors affecting neurological recovery following spinal cord injury. Injury. 1997;28:545–548. doi:10.1016/S0020-1383(97)00090-9. PMID: 9616393.
   PubMed Web of Science ®Google Scholar
• Tsutsumi S, Ueta T, Shiba K, Yamamoto S, Takagishi K. Effects of the second national acute spinal cord injury study of high-dose methylprednisolone therapy on acute cervical spinal cord injury-results in spinal injuries center. Spine (Phila Pa 1976). 2006;31:2992–2997. doi:10.1097/01.brs.0000250273.28483.5c. PMID: 17172994.
   PubMed Web of Science ®Google Scholar
• Amar AP, Levy ML. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery. 1999;44:1027–1040. doi:10.1097/00006123-199905000-00052. PMID: 10232536.
   PubMed Web of Science ®Google Scholar
• Porter AG, Jänicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999;6:99–104. doi:10.1038/sj.cdd.4400476. PMID: 10200555.
   PubMed Web of Science ®Google Scholar
• Xu GY, Liu S, Hughes MG, McAdoo DJ. Glutamate-induced losses of oligodendrocytes and neurons and activation of caspase-3 in the rat spinal cord. Neuroscience. 2008;153:1034–1047.doi:10.1016/ j.neuroscience.2008.02.065. PMID: 18423997.
   PubMed Web of Science ®Google Scholar
• Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J. 2004;18:816–827. doi:10.1096/fj.03-1273rev. PMID: 15117886.
   PubMed Web of Science ®Google Scholar
• Liu XZ, Xu XM, Hu R, et al. Neuronal and glial apoptosis after traumatic spinal cord injury. J Neurosci. 1997;17:5395–5406. PMID: 9204923.
   PubMed Web of Science ®Google Scholar
• Kubota K, Saiwai H, Kumamaru H, et al. Myeloperoxidase exacerbates secondary injury by generating highly reactive oxygen species and mediating neutrophil recruitment in experimental spinal cord injury. Spine (Phila Pa 1976). 2012;37:1363–1369. doi:10.1097/BRS.0b013e31824b9e77. PMID: 22322369.
   PubMed Web of Science ®Google Scholar
• Buss A, Pech K, Kakulas BA, et al. TGF-beta1 and TGF-beta2 expression after traumatic human spinal cord injury. Spinal Cord. 2008;46:364–371. doi:10.1038/sj.sc.3102148. PMID: 18040277.
   PubMedGoogle Scholar